Found: 6
Select item for more details and to access through your institution.
Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans.
- Published in:
- British Journal of Pharmacology, 2013, v. 168, n. 2, p. 339, doi. 10.1111/j.1476-5381.2012.02184.x
- By:
- Publication type:
- Article
[<sup>3</sup>H]BHDP as a novel and selective ligand for σ1 receptors in liver mitochondria and brain synaptosomes of the rat
- Published in:
- FEBS Letters, 2003, v. 553, n. 1/2, p. 157, doi. 10.1016/S0014-5793(03)01011-1
- By:
- Publication type:
- Article
A Synthetic Polyphenol, S17834, Protects Against Hepatic Lipid Accumulation in Type 1 Diabetic Mice: Role of AMPK and SREBP.
- Published in:
- Diabetes, 2007, v. 56, p. A392
- By:
- Publication type:
- Article
The Synthetic Polyphenol and AMPK Activator, S17834, Improves Diet-Induced Obesity, Insulin Resistance, Hyperlipidemia, and Atherosclerosis in LDL Receptor Deficient Mice.
- Published in:
- Diabetes, 2007, v. 56, p. A192
- By:
- Publication type:
- Article
The Role of Sirt1 Activation of AMP-Activated Protein Kinase in the Effect of Polyphenols on Lipid Metabolism in HepG2 Cells Exposed to High Glucose.
- Published in:
- Diabetes, 2007, v. 56, p. A98
- By:
- Publication type:
- Article
Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor-Deficient Mice.
- Published in:
- Diabetes, 2006, v. 55, n. 8, p. 2180, doi. 10.2337/db05-1188
- By:
- Publication type:
- Article